Last Modified: January 29, 2010
Conference Dates: September 19-21, 2010
Conference Location: Edinburgh
Sponsoring Group: Eyal Gottlieb and Karen Vousden (The Beatson Institute for Cancer Research, UK)
Conference Web Page URL: www.abcam.com/index.html?pageconfig=resource&rid=12304
Topics Covered: - All the major aspects of metabolic transformation in cancer - Potential therapeutic approaches that target cancer-specific metabolic pathways - Role of metabolism in tumorigenesis
Who Should Attend: Open to all
Conference Agenda: This workshop will cover all the major aspects of metabolic transformation in cancer and will highlight potential therapeutic approaches that target cancer-specific metabolic pathways.
Registration Information: Space is limited to 150 seats. Places will be allocated on a first register/first served basis, so register early to avoid disappointment! Please note: All prices include VAT. Students are categorized as those in full time education at the time of registering. Proof of student status may be requested.
Conference Fees: Refer to site, Early bird rate available
Continuing Education: No
Nov 29, 2010 - Dextromethorphan, a known "probe drug" for both CYP2D6 and CYP3A4 metabolism, can be used as a phenotyping probe for tamoxifen metabolism in women who must take tamoxifen for breast cancer treatment, according to research presented at the European Organisation for Research and Treatment of Cancer/National Cancer Institute/American Association for Cancer Research Symposium on Molecular Targets and Cancer Therapeutics, held from Nov. 16 to 19 in Berlin.
Mar 4, 2015